Sperling Prostate Center

Category: Prostate Cancer

A New Product to Reduce Rectal Damage from Prostate Radiation

More Cancer Deaths Due to Pandemic Delays in Treatment? | Sperling Prostate Center
The use of an injectable hydrogel spacer to help minimize toxic effects of prostate cancer (PCa) radiation on the rectal wall has become a standard of care. By implanting the hydrogel into the tissue between the prostate and the rectum, a wider space is created, which “may significantly reduce the [radiation] dose received by the rectum and the risk of rectal toxicity [side effects, see explanation in the blog below].” How well does it work? keep reading

“New” Focal Prostate Cancer Treatment? More Questions Than Answers

Radiofrequency ablation for prostate cancer
“Introducing the ultimate technology in Precision Medicine for Prostate Focal Therapy.” “TSPA is the only technology designed for Prostate Focal Therapy” These bold claims announce the availability of Tissue Sparing Prostate Ablation (TSPA), known by its brand name as Encage. Encage uses a specific type of radiofrequency ablation (RFA), which basically cooks a tumor by keep reading

Artificial Intelligence in Medicine: Predicting Prostate Cancer Progression During Active Surveillance

“Despite increasing adoption of active surveillance (AS) for low-risk prostate cancer, AS discontinuation rates are high, investigators report.” This quote, from a September 2021 Renal & Urology News report, referred to a study of over 16,000 Canadian prostate cancer (PCa) patients who had been diagnosed with low risk disease from 2008-2014. 51% of these patients keep reading
WordPress Image Lightbox